USA - NASDAQ:DMAQ - US2437331026 - Common Stock
The current stock price of DMAQ is 2.96 USD. In the past month the price decreased by -74.37%. In the past year, price decreased by -70.61%.
Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Plantation, Florida. The company went IPO on 2021-10-27. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on the healthcare and education service industries. The firm is not engaged in any business operations and has not generated any revenue.
DEEP MEDICINE ACQUISITI-CL A
7951 S.W. 6Th Street, Suite 216
Plantation FLORIDA US
Employees: 0
Phone: 19544242345
Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Plantation, Florida. The company went IPO on 2021-10-27. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on the healthcare and education service industries. The firm is not engaged in any business operations and has not generated any revenue.
The current stock price of DMAQ is 2.96 USD. The price decreased by -64.72% in the last trading session.
DMAQ does not pay a dividend.
DMAQ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
DEEP MEDICINE ACQUISITI-CL A (DMAQ) has a market capitalization of 12.91M USD. This makes DMAQ a Nano Cap stock.
ChartMill assigns a fundamental rating of 1 / 10 to DMAQ. The financial health of DMAQ is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months DMAQ reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -466.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.1% | ||
| ROE | -22.17% | ||
| Debt/Equity | 0 |